Abstract

The NLRP3 inflammasome is a multi-protein complex that initiates innate immunity responses when exposed to a wide range of stimuli, including pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). Inflammasome activation leads to the release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18 and to pyroptotic cell death. Over-activation of NLRP3 inflammasome has been associated with several chronic inflammatory diseases. A deep knowledge of NLRP3 inflammasome biology is required to better exploit its potential as therapeutic target and for the development of new selective drugs. To this purpose, in the past few years, several tools have been developed for the biological characterization of the multimeric inflammasome complex, the identification of the upstream signaling cascade leading to inflammasome activation, and the downstream effects triggered by NLRP3 activation. In this review, we will report cellular models and cellular, biochemical, and biophysical assays that are currently available for studying inflammasome biology. A special focus will be on those models/assays that have been used to identify NLRP3 inhibitors and their mechanism of action.

Highlights

  • Innate immunity represents the first line of defense against invading pathogens or endogenous stress signals

  • The inflammatory cascade is triggered by the recognition of pathogen-associated molecular pattern (PAMP) and danger-associated molecular pattern (DAMP) by pattern recognition receptors (PRRs) that are mainly expressed by immune cells, such as macrophages

  • Inflammasome assembly occurs upon activation of the TLR4 by LPS triggering the TIR-domain-containing adapter-inducing interferon-β (TRIF)—receptor-interacting serine/threonine-protein kinase 1 (RIPK1)—Fas-associated protein with death domain (FADD) caspase-8 signaling cascade, which in turns leads to the activation of the NLRP3 inflammasome

Read more

Summary

Introduction

Innate immunity represents the first line of defense against invading pathogens or endogenous stress signals. It exists in human and porcine peripheral blood mononuclear cells (PBMCs), but it is absent in murine ones [32] In this pathway, LPS per se is sufficient to induce activation of the NLRP3 inflammasome with consequent activation of caspase-1 and IL-1β processing and secretion. Inflammasome assembly occurs upon activation of the TLR4 by LPS triggering the TIR-domain-containing adapter-inducing interferon-β (TRIF)—receptor-interacting serine/threonine-protein kinase 1 (RIPK1)—Fas-associated protein with death domain (FADD) caspase-8 signaling cascade, which in turns leads to the activation of the NLRP3 inflammasome. This pathway is not dependent on K+ efflux. IL-1β is released gradually, as opposed to the all-or-nothing response of the canonical activation [32]

Role of Domains
Inhibition of NLRP3 for the Treatment of Inflammatory Diseases
Cell Models to Study NLRP3 Inflammasome Biology
Murine Cell Models
Murine Macrophage Cell Lines
Human Cell Models
BlaER1 Human Cell Model
HEK293T Cell Line
The Importance of Choosing the Right Model
Immuno-Based Assays
Probe-Based Assays
Cell Death Assays
Concluding Remarks
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call